Literature DB >> 23238804

Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.

Fabian Stavenuiter1, Nicole F Davis, Erning Duan, Andrew J Gale, Mary J Heeb.   

Abstract

Anticoagulant plasma protein S (PS) is essential for maintaining haemostatic balance. About 2.5% of PS is stored in platelets and released upon platelet stimulation. So far, little is known about the functionality and importance of platelet (plt)PS. A platelet-associated protease cleaves plasma-derived (pd)PS and pltPS in the "thrombin-sensitive region", abolishing activated protein C (APC) cofactor activity. However, we showed that cleaved PS retains APC-independent anticoagulant activities ("PS-direct"). To investigate whether pltPS or pdPS exert PS-direct on platelets or platelet-shed microparticles, thrombin and factor (F)Xa generation on unstimulated or stimulated washed platelets and microparticles were measured. Western blotting revealed that pltPS and pdPS bound to washed, stimulated platelets and microparticles, and that pltPS had slower electrophoretic mobility than pdPS. Platelet stimulation in the presence of inhibitory anti-PS antibodies resulted in 2.6 ± 1.6-fold (p<0.0004, n=20) more thrombin generation upon addition of FXa and prothrombin. PltPS exerted PS-direct that was similar to or greater than that of Zn(2+)-containing pdPS and much greater than that of Zn(2+)-deficient pdPS. Findings were confirmed using purified pltPS. Platelet-bound pltPS and microparticle-bound pltPS had similar PS-direct. Finally, platelet stimulation in the presence of inhibitory anti-PS antibodies resulted in 1.5 ± 0.2-fold (p<0.0001, n=11) more FXa generation upon addition of TF/FVIIa and FX. Thus, pltPS inhibits both prothrombinase and extrinsic FXase activities. Neutralising antibodies against APC and TFPI had no effect on the PS-direct of pltPS or pdPS on platelets. This study indicates that pltPS may be an essential pool of PS that counterbalances procoagulant activities on platelets.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238804      PMCID: PMC3564957          DOI: 10.1160/TH12-08-0622

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  32 in total

1.  Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals.

Authors:  M J Heeb; R R Koenen; J A Fernández; T M Hackeng
Journal:  J Thromb Haemost       Date:  2004-10       Impact factor: 5.824

2.  Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin.

Authors:  D D Monković; P B Tracy
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

3.  Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.

Authors:  G Tans; J Rosing; M C Thomassen; M J Heeb; R F Zwaal; J H Griffin
Journal:  Blood       Date:  1991-06-15       Impact factor: 22.113

4.  Protein S is required for bovine platelets to support activated protein C binding and activity.

Authors:  K W Harris; C T Esmon
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

5.  Cleavage of protein S by a platelet membrane protease.

Authors:  C A Mitchell; H H Salem
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

6.  Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection.

Authors:  S Solymoss; M M Tucker; P B Tracy
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

7.  Identification and quantitation of protein S in human platelets.

Authors:  H P Schwarz; M J Heeb; J D Wencel-Drake; J H Griffin
Journal:  Blood       Date:  1985-12       Impact factor: 22.113

8.  Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation.

Authors:  M J Heeb; D Mosher; J H Griffin
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

9.  Activation of coagulation factor V by a platelet protease.

Authors:  W H Kane; J S Mruk; P W Majerus
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation.

Authors:  A Lundwall; W Dackowski; E Cohen; M Shaffer; A Mahr; B Dahlbäck; J Stenflo; R Wydro
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

View more
  11 in total

1.  State of the art in platelet function testing.

Authors:  Beate E Kehrel; Martin F Brodde
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

2.  Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.

Authors:  Fabian Stavenuiter; Andrew J Gale; Mary J Heeb
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

3.  Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.

Authors:  Mary J Heeb; Rolf M Mesters; José A Fernández; Tilman M Hackeng; Ryon K Nakasone; John H Griffin
Journal:  Thromb Haemost       Date:  2013-05-23       Impact factor: 5.249

4.  Platelet anticoagulant proteins: Modulators of thrombosis propensity within a procoagulant cell.

Authors:  Amy E Siebert; Alan E Mast
Journal:  J Thromb Haemost       Date:  2020-07-30       Impact factor: 5.824

Review 5.  Platelet-Derived Microvesicles in Cardiovascular Diseases.

Authors:  Maria T K Zaldivia; James D McFadyen; Bock Lim; Xiaowei Wang; Karlheinz Peter
Journal:  Front Cardiovasc Med       Date:  2017-11-21

6.  Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome.

Authors:  Dong Ling Tong; Karen E Kempsell; Tamas Szakmany; Graham Ball
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

7.  Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-14       Impact factor: 8.311

8.  Phospholipid Binding Protein C Inhibitor (PCI) Is Present on Microparticles Generated In Vitro and In Vivo.

Authors:  Katrin Einfinger; Sigrun Badrnya; Margareta Furtmüller; Daniela Handschuh; Herbert Lindner; Margarethe Geiger
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

Review 9.  Interplay between platelets and coagulation.

Authors:  Yaqiu Sang; Mark Roest; Bas de Laat; Philip G de Groot; Dana Huskens
Journal:  Blood Rev       Date:  2020-07-12       Impact factor: 10.626

10.  A novel mutation Gly222Arg in PROS1 causing protein S deficiency in a patient with pulmonary embolism.

Authors:  Jingqing Xu; Gehong Peng; Yao Ouyang
Journal:  J Clin Lab Anal       Date:  2019-11-19       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.